eLearning modules

These CPD modules have been developed in partnership with pharmaceutical companies and may contain pharmaceutical promotional information. Please also see: Guidelines Learning

Deep dive on DPP-4 inhibitors with a focus on Trajenta® (linagliptin)

Promotional material from Boehringer Ingelheim Limited

This eLearning module and the associated videos have been commissioned and funded by Boehringer Ingelheim. The module and associated videos contain promotional content. For UK healthcare professionals.
View Trajenta^® (linagliptin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
View Jardiance^® (empagliflozin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
PC-GB-104526 July 2021